Distinct from the PD-L1 expression profile, which is overexpressed in TNBC (when compared to hormonal receptor positive or HER2+ breast cancer subtypes), PD1 levels varied little among the cell lines across different subtypes (Supplementary information, Fig. S1c). This evidence concerns the gene ERBB2 and breast carcinoma.